Their findings are being presented at the annual meeting of the Infectious Diseases Society of America to be held in Vancouver, Canada on Friday, Oct. 22.

Phil Chan, MD, an infectious diseases fellow at Rhode Island Hospital, studied the signs, symptoms, and laboratory findings of 668 adult and pediatric patients who were treated at Rhode Island Hospital or its partner, The Miriam Hospital, between October and December 2009 with a confirmed viral infection.

Chan says, "Compared to patients with other viruses, individuals with novel Influenza A, or H1N1, were more likely to present with subjective fever, cough, sore throat, nausea/vomiting. The mean white blood count of patients with H1N1 is lower than with other viruses as well."

Leonard Mermel, DO, medical director of epidemiology and infection control at Rhode Island Hospital and professor of medicine at The Warren Alpert Medical School of Brown University, is a co-author. Mermel adds, "Perhaps more striking is that patients with the novel Influenza A virus may have higher mortality rates compared to other respiratory viruses in the patients studied. As a result of this study, and based on available data in the literature, we recommend that high-risk patients infected with novel Influenza A receive expedient antiviral therapy." Mermel is also a physician with University Medicine.

In his presentation, Chan will provide more details on the findings of this study.

Other researchers in the study with Chan and Mermel include Kimberle Chapin, MD; Saran Andrea, Russell McCulloh, MD; John Mills, MD; Ignacio Echenique, MD; Emily Leveen, MD; Natasha Rybak, MD; Cheston Cunha, MD, Jason Machan, PhD, all of Rhode Island and Miriam hospitals and Alpert Medical School.

Note: If no author is given, the source is cited instead.

• Today's Healthcare
• Infectious Diseases
• Viruses

• Virology
• Microbes and More
• Veterinary Medicine

• Human parainfluenza viruses
• Upper respiratory tract infection
• Transmission (medicine)
• Flu vaccine
• Nasal congestion
• Pandemic